Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Goldman Sachs Downgrades Calyxt Inc. (CLXT) to Neutral Following Q4 EPS
March 5, 2020 7:15 PM ESTGoldman Sachs analyst Adam Samuelson downgraded Calyxt Inc. (NASDAQ: CLXT) from Buy to Neutral with a price target of $7.00 (from $19.00).
For an analyst ratings summary and ratings history on Calyxt Inc. click here. For more ratings news on Calyxt Inc. click here.
Shares of Calyxt Inc. closed at $6.56 yesterday.
... MoreCellectis (CLLS) Tops Q4 EPS by 19c
March 4, 2020 4:33 PM ESTCellectis (NASDAQ: CLLS) reported Q4 EPS of ($0.54), $0.19 better than the analyst estimate of ($0.73). Revenue for the quarter came in at $3.08 million versus the consensus estimate of $4.95 million.
For earnings history and earnings-related data on Cellectis (CLLS) click here.
... More